Groh, Ana M.
Vehreschild, Maria J. G. T.
Diaz, Damian
Kuchta, Alison L.
Dodoo, Christopher
Alvarado, Luis A.
Parkin, Neil T.
Robbins, Elissa M.
Moonsamy, Priscilla
Toptan, Tuna
Ciesek, Sandra
Berger, Annemarie
Funding for this research was provided by:
Roche Molecular Systems
Johann Wolfgang Goethe-Universität, Frankfurt am Main
Article History
Received: 31 January 2024
Accepted: 22 May 2024
First Online: 29 May 2024
Competing interests
: This study was funded by Roche Molecular Systems. ALK, CD, LAA, EMR and PM are employees of Roche Molecular Systems, and ALK and EMR are also stockholders. NTP is a contractor to Roche Molecular Systems. AMG, DD, TT, SC, and AB declare no competing interests. MJGTV has received research grants from 3M, Astellas Pharma, Biontech, DaVolterra, Evonik, Gilead Sciences, Glycom, Immunic, MaaT Pharma, Merck/MSD, Organobalance, Seres Therapeutics, and Takeda Pharmaceutical; as well as consulting and speaker fees from Astellas Pharma, Basilea, Bio- Mérieux, DaVolterra, Farmak International Holding GmbH, Ferring, Gilead Sciences, Immunic AG, MaaT Pharma, Merck/MSD, Pfizer, Roche, Organobalance, SocraTec R&D GmbH, and Tillots Pharma. Assay reagents for diagnostic testing were provided by Roche.